About G-protein coupled receptor 15
G-protein coupled receptor 15 (GPR15) is a protein
from Homo sapiens identified by UniProt accession
P49685, 360 residues long.
MolForge cross-references it against 0 known binders and
236 disease associations.
Target properties
| Protein name | G-protein coupled receptor 15 |
| UniProt accession | P49685 |
| Gene | GPR15 |
| Organism | Homo sapiens |
| Length | 360 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (236)
Diseases linked to this target (Open Targets).
- ulcerative colitis · score 0.09
- neoplasm · score 0.08
- cancer · score 0.08
- myocardial infarction · score 0.08
- isolated agammaglobulinemia · score 0.07
- colitis · score 0.07
- common variable immunodeficiency · score 0.07
- T-B+ severe combined immunodeficiency due to JAK3 deficiency · score 0.06
- Immunodeficiency by defective expression of HLA class 2 · score 0.06
- Autosomal recessive early-onset inflammatory bowel disease · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P49685-F1 | alphafold | PREDICTED | 81.85 | — |
Amino-acid sequence (360 residues)
MDPEETSVYL DYYYATSPNS DIRETHSHVP YTSVFLPVFY TAVFLTGVLG NLVLMGALHF KPGSRRLIDI FIINLAASDF IFLVTLPLWV DKEASLGLWR TGSFLCKGSS YMISVNMHCS VLLLTCMSVD RYLAIVWPVV SRKFRRTDCA YVVCASIWFI SCLLGLPTLL SRELTLIDDK PYCAEKKATP IKLIWSLVAL IFTFFVPLLS IVTCYCCIAR KLCAHYQQSG KHNKKLKKSI KIIFIVVAAF LVSWLPFNTF KFLAIVSGLR QEHYLPSAIL QLGMEVSGPL AFANSCVNPF IYYIFDSYIR RAIVHCLCPC LKNYDFGSST ETSDSHLTKA LSTFIHAEDF ARRRKRSVSL
Explore G-protein coupled receptor 15 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets